Penhance 125 mg/25 mg Injection is used to treat bacterial infections of the ear, nose, throat, skin, bone, soft tissue, joints, urinary tract, and respiratory tract.

Penhance 125 mg/25 mg Injection contains Amoxycillin and Clavulanic acid. Amoxycillin kills bacteria by preventing the formation of bacterial cell covering, which is necessary for their survival. Clavulanic acid decreases bacterial resistance and enhances the activity of Amoxycillin against bacteria. Together, Penhance 125 mg/25 mg Injection helps treat bacterial infections.

In some cases, Penhance 125 mg/25 mg Injection may cause side effects, such as pain and swelling at the injection site, skin rashes, nausea, vomiting, bloating, and gas. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Please inform your doctor if you are pregnant or breastfeeding. Penhance 125 mg/25 mg Injection may cause dizziness, so drive with caution. Inform your doctor about all the medicines you are taking and about your health condition to rule out any unpleasant side effects.

Penhance 125 mg/25 mg Injection is used in the treatment of bacterial infections. The detailed uses of Penhance 125 mg/25 mg Injection are as follows:

• Bacterial Infections: Penhance 125 mg/25 mg Injection is commonly used to treat bacterial infections, particularly those resistant to other antibiotics.
• Respiratory Infections: Penhance 125 mg/25 mg Injection can effectively treat respiratory infections like pneumonia and bronchitis caused by bacteria.
• Skin Infections: Penhance 125 mg/25 mg Injection treats skin and soft tissue infections like cellulitis and abscesses caused by susceptible bacteria.
• Urinary Tract Infections: Penhance 125 mg/25 mg Injection can treat complicated urinary tract infections (UTIs) caused by susceptible bacteria.
• Post-Surgical Infections: Penhance 125 mg/25 mg Injection may be administered to prevent or treat infections arising from surgical procedures, especially in cases where the risk of infection is high.

• Penhance 125 mg/25 mg Injection is administered by a healthcare professional through an intravenous (IV) injection or infusion in a hospital or clinical setting. The healthcare provider will determine the appropriate dosage and administration rate.
• Do not self-administer.

• Penhance 125 mg/25 mg Injection is effective against bacterial infections of the ear, nose, throat, skin, bone, soft tissue, joints, urinary tract, and respiratory tract.
• It works against both gram-positive and gram-negative bacteria, covering a wide variety of infection-causing organisms.
• Amoxicillin inhibits bacterial cell wall formation, leading to bacterial death and stopping the spread of infection.
• Clavulanic acid blocks the beta-lactamase enzyme, protecting amoxicillin from bacterial resistance and ensuring effective treatment.
• Penhance 125 mg/25 mg Injection reduces infection severity and promotes quicker recovery.
• By overcoming resistant bacteria, it lowers the risk of infection coming back.

• Do not take Penhance 125 mg/25 mg Injection if you are allergic to any of the contents or have jaundice.
• Inform your doctor if you have glandular fever, inflammation of the intestine, fits, liver/kidney problems or if you are unable to pass urine regularly.
• Consult your doctor before taking Penhance 125 mg/25 mg Injection if you are pregnant or breastfeeding.
• Penhance 125 mg/25 mg Injection may cause dizziness, so drive with caution.
• Avoid alcohol consumption while taking Penhance 125 mg/25 mg Injection to prevent unpleasant side effects.
• Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects.